From: Low BCL9 expression inhibited ovarian epithelial malignant tumor progression by decreasing proliferation, migration, and increasing apoptosis to cancer cells
Group
n
BCL9
Positive cases
Positive rate %
(−)
(+)
(++)
(+++)
Malignant#
61
11
21
13
16
51
81.97
Borderline**
3
4
10
76.92
Benign*
8
1
0
5
38.46
Normal
12